CRGGH News


News


Dr. Rotimi receives HudsonAlpha Life Sciences Prize

Richard Myers and Charles Rotimi

By Amy Bentley

In recognition of his "unique and significant contributions to the field of genomics," Center Director Charles Rotimi, Ph.D., has been presented with the 2018 HudsonAlpha Life Sciences Prize from the HudsonAlpha Institute for Biotechnology. This prize is given to honor life sciences research that seeks to improve human or environmental health, or agricultural yields, while elevating research careers and endeavors for current and future biotechnology students.

Read more

Posted: Monday, May 7, 2018



A New Look at the Origin of the Sickle Allele

Sickle Cells

By Amy Bentley

CRGGH researchers Daniel Shriner and Charles Rotimi have used whole genome sequence data to investigate the origin of the mutation that causes sickling of red blood cells, which reduces their ability to carry oxygen and can have lethal consequences in individuals that have two copies of the mutation. Five haplotypes containing this mutation have been defined (Arabian/Indian, Benin, Cameroon, Central African Republic/Bantu, and Senegal), each representing what has been thought to be an independent occurrence of the mutation. These haplotypes have been associated with different degrees of clinical severity. In addition, there are several haplotypes that do not correspond to the five ethno-linguistic groups or geographic regions and are referred to as atypical.

Read more

Posted: Thursday, March 15, 2018



Upcoming CDC-NIH Webinar on Precision Medicine and Health Disparities

By Amy Bentley

The rise in Precision Medicine has uncertain implications for population health disparities. On October 11, 2017 from 3:00-4:00 PM (EDT), the Director of the Center for Research on Genomics and Global Health, Dr. Charles Rotimi, will join Dr. Wylie Burke, Professor of the Department of Bioethics and Humanities at the University of Washington, for a webinar to discuss "Precision Medicine and Health Disparities: The Promise and Perils of Emerging Technologies." This webinar has been collaboratively sponsored by groups at the National Institutes of Health and the Centers for Disease Control and Prevention. More details and free registration available here.

Posted: Thursday, September 14, 2017



President Gurib-Fakim of Mauritius Supports H3Africa Initiative

By Amy Bentley, CRGGH

In October, African scientists and collaborators gathered in Pointe aux Piments in Mauritius for the 9th Human Health and Heredity in Africa (H3Africa) Consortium Meeting. Attendees were honored to host the President of Mauritius, Dr. Ameenah Gurib-Fakim (front row, third from right), at this meeting. Dr. Gurib-Fakim delivered the opening address for the meeting, highlighting the significance of this initiative in supporting African youth, encouraging them to remain on the continent to contribute their expertise. Read more

Posted: Friday, January 6, 2017



H3Africa Consortium Array Will Bring Leading-Edge Genomics Tool to Address African Genomic Diversity

By Amy Bentley, CRGGH

In a major advance for those engaged in genomic research in African ancestry populations, Illumina will be developing a GWAS array based on data from the Human Heredity and Health in Africa Initiative (H3Africa). This array will include novel content based on sampling of individuals from populations across Africa. This tool promises to address a key limitation of current research efforts in terms of trying to interrogate the genomes of African ancestry individuals with tools that were not designed to sufficiently capture the genomic diversity of these individuals. This extraordinary effort has been driven by the H3Africa Genome Analysis Working Group, of which CRGGH?s Deputy Director, Adebowale Adeyemo, serves as co-chair.

More information about this achievement is available through Illumina and Quartz Africa.



Posted: Monday, November 14, 2016